Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results GlobeNewswire December 08, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that it has sold approximately 4.1 million shares of Class A Common Stock of Ryan Specialty Holdings, Inc. […]

Digi Power X Appoints Chief Technology Officer GlobeNewswire December 08, 2025 This news release constitutes a “designated news release” for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) — Digi Power X

Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) GlobeNewswire December 08, 2025 — Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria — — Bezuclastinib demonstrated a

Gray Announces Private Placement of $250 Million of Additional 9.625% Senior Secured Second Lien Notes due 2032 GlobeNewswire December 08, 2025 ATLANTA, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today it entered into purchase agreements (the “Purchase Agreements”) with certain accredited investors (collectively, the “Investors”), pursuant to which Gray

Dragonfly Energy Expands Marine OEM Footprint with World's Largest Power Catamaran Manufacturer, World Cat GlobeNewswire December 08, 2025 RENO, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries(R), today announced that World Cat, the

BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review GlobeNewswire December 08, 2025 Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011, its phage program for Staphylococcus aureus (S. aureus) infections associated

Gemini to Participate in Goldman Sachs 2025 Financial Services Conference GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) today announced that Marshall Beard, Chief Operating Officer, and Dan Chen, Chief Financial Officer, will attend the Goldman Sachs 2025 Financial Services Conference on December 9,

Abeona Therapeutics(R) Announces First Patient Treatment with ZEVASKYN(R) Gene Therapy GlobeNewswire December 08, 2025 CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a first-of-its-kind, autologous gene therapy for treating wounds in adult and pediatric patients with recessive dystrophic epidermolysis

Stock Yards Bancorp Announces Promotion of William Otten to Chief Credit Officer of the Company as William Dishman Sets Retirement Date GlobeNewswire December 08, 2025 LOUISVILLE, Ky., Dec. 08, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern

Toronto, Ontario–(Newsfile Corp. – December 8, 2025) – Canstar Resources Inc. (TSXV: ROX) (OTCID: CSRNF) (“Canstar” or the “Company”) is pleased to provide an update on its collaboration with Terra AI “Terra”), a Silicon Valley-based company applying machine learning to accelerate mineral exploration. The two companies announced a Letter of Intent (“LOI”) in June 2025